Table 3.
Cardiac Death rate
| |||||
---|---|---|---|---|---|
Quartile
|
P | ||||
1st | 2nd | 3rd | 4th | ||
|
|||||
Age | 20.6% (26.8%) | 27.9% (39.9%) | 39.7% (45.9%) | 67.1% (54.2%) | ≤0.0001 |
LVEF | 66.1% (50.9%) | 59.5% (47.5%) | 28.0% (42.7%) | 23.9% (37.1%) | ≤0.0001 |
GRK2 | 15.9% (28.3%) | 26.6% (39.9%) | 59.1% (48.2%) | 56.3% (58.0%) | ≤0.0001 |
NT-proBNP | 9.23% (20.7%) | 23.3% (38.8%) | 47.1% (47.7%) | 78.1% (58.3%) | ≤0.0001 |
All Cause Death rate
| |||||
---|---|---|---|---|---|
Quartile
|
P | ||||
1st | 2nd | 3rd | 4th | ||
|
|||||
Age | 30.2% (39.8%) | 44.3% (52.2%) | 52.4% (57.5%) | 74.3% (64.4%) | ≤0.0001 |
LVEF | 89.3% (65.4%) | 62.2% (60.6%) | 37.6% (53.6%) | 32.4% (45.0%) | ≤0.0001 |
GRK2 | 23.8% (39.1%) | 34.4% (52.0%) | 75.8% (60.5%) | 68.8% (69.9%) | ≤0.0001 |
NT-proBNP | 21.5% (32.4%) | 36.8% (52.1%) | 58.8% (60.6%) | 85.9% (70.1%) | ≤0.0001 |
Boldface data refer to Cox adjusted cumulative death rate at 60 months. LVEF= left ventricular ejection fraction; GRK2= G protein-coupled receptor kinase 2; NT-proBNP= N terminal pro-Brain Natriuretic Peptide